We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Ranked Momentum Stocks to Buy for November 17th
Read MoreHide Full Article
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 17th:
Semler Scientific, Inc. : This company that develops, manufactures, and markets proprietary products that assist healthcare providers has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.7% over the last 60 days.
Semler Scientific’s shares gained 36.6% over the last one month compared with the S&P 500’s growth of 4.1%. The company possesses a Momentum Score of A.
Fulgent Genetics, Inc. (FLGT - Free Report) : This genetic testing services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Charles & Colvard, Ltd. (CTHR - Free Report) : This company that manufacture, market and distribute moissanite jewels has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Regional Management Corp. (RM - Free Report) : This diversified consumer finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.3% over the last 60 days.
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for November 17th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, November 17th:
Semler Scientific, Inc. : This company that develops, manufactures, and markets proprietary products that assist healthcare providers has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 61.7% over the last 60 days.
Semler Scientific Inc. Price and Consensus
Semler Scientific Inc. price-consensus-chart | Semler Scientific Inc. Quote
Semler Scientific’s shares gained 36.6% over the last one month compared with the S&P 500’s growth of 4.1%. The company possesses a Momentum Score of A.
Semler Scientific Inc. Price
Semler Scientific Inc. price | Semler Scientific Inc. Quote
Fulgent Genetics, Inc. (FLGT - Free Report) : This genetic testing services provider has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Fulgent Genetics, Inc. Price and Consensus
Fulgent Genetics, Inc. price-consensus-chart | Fulgent Genetics, Inc. Quote
Fulgent Genetics’ shares gained nearly 29% over the last one month. The company possesses a Momentum Score of A.
Fulgent Genetics, Inc. Price
Fulgent Genetics, Inc. price | Fulgent Genetics, Inc. Quote
Charles & Colvard, Ltd. (CTHR - Free Report) : This company that manufacture, market and distribute moissanite jewels has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Charles & Colvard Ltd Price and Consensus
Charles & Colvard Ltd price-consensus-chart | Charles & Colvard Ltd Quote
Charles & Colvard’s shares gained 15.7% over the last one month. The company possesses a Momentum Score of A.
Charles & Colvard Ltd Price
Charles & Colvard Ltd price | Charles & Colvard Ltd Quote
Regional Management Corp. (RM - Free Report) : This diversified consumer finance company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 40.3% over the last 60 days.
Regional Management Corp. Price and Consensus
Regional Management Corp. price-consensus-chart | Regional Management Corp. Quote
Regional Management’s shares gained 15.9% over the last one month. The company possesses a Momentum Score of A.
Regional Management Corp. Price
Regional Management Corp. price | Regional Management Corp. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Legal Marijuana: An Investor’s Dream
Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.
Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.
Download Marijuana Moneymakers FREE >>